2010 BC Guide in Determining Fitness to Drive
2010 BC Guide in Determining Fitness to Drive 2010 BC Guide in Determining Fitness to Drive
7.2 Components of driver fitness determinations ........................................................... 537.3 Making driver fitness determinations for persistent and episodic impairments . 547.4 Making driver fitness determinations for individuals whose cognitive ability todrive may be persistently impaired ............................................................................. 557.5 Making driver fitness determinations for individuals whose motor or sensoryfunction may be impaired or who may have episodic impairment of cognitivefunction ............................................................................................................................ 567.6 Reviewing driving records ............................................................................................ 587.7 Considering specific driving or safety requirements................................................ 597.8 Considering whether an individual can compensate ................................................ 607.9 Imposing restrictions and/or conditions ..................................................................... 627.10 Considering compliance with conditions or restrictions ......................................... 647.11 Determining re-assessment intervals .......................................................................... 667.12 Communicating a decision............................................................................................ 717.13 Determination procedures ............................................................................................ 73Chapter 8: Reconsideration Policies and Procedures .......................................................... 748.1 Overview .......................................................................................................................... 748.2 Conducting reconsiderations........................................................................................ 758.3 Reconsideration procedures ......................................................................................... 77PART 3: MEDICAL CONDITION CHAPTERS ...................................................................... 78Chapter 9: Introduction to the Medical Condition Chapters ............................................. 799.1 Purpose of the medical condition chapters ................................................................ 799.2 Source of the medical condition chapters .................................................................. 799.3 Source of the medical condition guidelines ................................................................ 809.4 Medical condition chapter template............................................................................ 81Medical condition.............................................................................................................................. 81BACKGROUND ........................................................................................................................... 81About the medical condition ....................................................................................................... 81Prevalence and incidence of the medical condition ................................................................. 81The medical condition and adverse driving outcomes ............................................................ 81Effect of the medical condition on functional ability to drive ............................................... 81Compensation ................................................................................................................................ 82GUIDELINES ............................................................................................................................... 82Private and commercial drivers who have X ........................................................................... 83Chapter 10: Medical Conditions at-a-Glance .......................................................................... 84Chapter 11: Diabetes – Hypoglycemia ...................................................................................... 85BACKGROUND ........................................................................................................................... 8511.1 About diabetes and hypoglycemia ............................................................................... 8511.2 Prevalence and incidence of diabetes and hypoglycemia ........................................ 8611.3 Diabetes and adverse driving outcomes ..................................................................... 8811.4 Effect of diabetes and hypoglycemia on functional ability to drive ....................... 8811.5 Compensation ................................................................................................................. 89GUIDELINES ............................................................................................................................... 9011.6 Private and commercial drivers with Type 2 diabetes that is not treated withinsulin or insulin secretagogues ................................................................................... 90v
11.7 Private and commercial drivers with Type 2 diabetes that is treated with insulinsecretagogues .................................................................................................................. 9111.8 Private drivers with diabetes treated with insulin .................................................... 9311.9 Commercial drivers with diabetes treated with insulin ........................................... 9511.10 Private drivers who have an episode of severe hypoglycemia ................................ 9811.11 Private drivers who have an episode of hypoglycemia unawareness................... 10011.12 Private drivers who have persistent hypoglycemia unawareness ........................ 10111.13 Commercial drivers who have an episode of severe hypoglycemia ..................... 10311.14 Commercial drivers who have an episode of hypoglycemia unawareness.......... 10511.15 Commercial drivers who have persistent hypoglycemia unawareness ............... 10711.16 Doctor’s report on commercial driver with diabetes on insulin ........................... 10811.17 Driver’s report – commercial driver with diabetes on insulin ............................. 110Chapter 12: Peripheral Vascular Diseases ............................................................................. 112BACKGROUND ......................................................................................................................... 11212.1 About peripheral vascular diseases ........................................................................... 11212.2 Prevalence and incidence of peripheral vascular diseases .................................... 11312.3 Peripheral vascular diseases and adverse driving outcomes ................................ 11412.4 Effect of peripheral vascular diseases on functional ability to drive ................... 11412.5 Compensation ............................................................................................................... 116GUIDELINES ............................................................................................................................. 11712.6 Private and commercial drivers with peripheral arterial disease ........................ 11712.7 Private drivers who have an aneurysm or dissection ............................................. 11912.8 Private and commercial drivers who have had surgery for an aneurysm ordissection ....................................................................................................................... 12012.9 Commercial drivers who have an aneurysm or dissection .................................... 12112.10 Private and commercial drivers who have deep-vein thrombosis........................ 122Chapter 13: Musculoskeletal Conditions................................................................................ 123BACKGROUND ......................................................................................................................... 12313.1 About musculoskeletal conditions ............................................................................. 12313.2 Prevalence and incidence of musculoskeletal conditions ....................................... 12313.3 Musculoskeletal conditions and adverse driving outcomes ................................... 12413.4 Effect of musculoskeletal conditions on functional ability to drive ..................... 12413.5 Compensation ............................................................................................................... 125GUIDELINES ............................................................................................................................. 12713.6 Private and commercial drivers who have lost a limb ........................................... 12713.7 Private and commercial drivers who have a chronic musculoskeletal condition......................................................................................................................................... 128Chapter 14: Chronic Renal Disease......................................................................................... 130BACKGROUND ......................................................................................................................... 13014.1 About chronic renal disease ....................................................................................... 13014.2 Prevalence and incidence of chronic renal disease ................................................. 13014.3 Chronic renal disease and adverse driving outcomes ............................................ 13114.4 Effect of chronic renal disease on functional ability to drive ................................ 13114.5 Compensation ............................................................................................................... 132GUIDELINES ............................................................................................................................. 13314.6 Private and commercial drivers with stage 1 or 2 renal disease .......................... 133vi
- Page 1 and 2: Ministry of Public Safety and Solic
- Page 3 and 4: AcknowledgmentsResearcherBonnie M.
- Page 5: Table of Contents (click on any ite
- Page 9 and 10: 17.7 Private and commercial drivers
- Page 11 and 12: 20.8 Private and commercial drivers
- Page 13 and 14: BACKGROUND ........................
- Page 15 and 16: PART 1:BACKGROUND1
- Page 17 and 18: Appendix 2: Excerpts from the MVA t
- Page 19 and 20: Chapter 2: The Driver Fitness Progr
- Page 21 and 22: for the exercise of discretion by O
- Page 23 and 24: 1. SCREENINGA driver disclosesa med
- Page 25 and 26: 2.3 Roles and responsibilitiesOSMV
- Page 27 and 28: Medical practitionersMedical practi
- Page 29 and 30: Chapter 3:Driver Fitness Program Pr
- Page 31 and 32: Because of these limitations, OSMV
- Page 33 and 34: Example: the temporary storage of i
- Page 35 and 36: Motor functions (including sensorim
- Page 37 and 38: an individual with poor contrast se
- Page 39 and 40: 3.5 Best informationDriver fitness
- Page 41 and 42: Chapter 4: Introduction to the Poli
- Page 43 and 44: 3. DETERMINATIONFrom2. AssessmentAn
- Page 45 and 46: Once identified, a DMER is mailed t
- Page 47 and 48: 5.3 Screening aging driversDefiniti
- Page 49 and 50: 5.5 Transient impairmentsDefinition
- Page 51 and 52: Chapter 6: Assessment Policies and
- Page 53 and 54: 6.2 Assessments will only be reques
- Page 55 and 56: 6.4 Requesting specialist assessmen
11.7 Private and commercial drivers with Type 2 diabetes that is treated with <strong>in</strong>sul<strong>in</strong>secretagogues .................................................................................................................. 9111.8 Private drivers with diabetes treated with <strong>in</strong>sul<strong>in</strong> .................................................... 9311.9 Commercial drivers with diabetes treated with <strong>in</strong>sul<strong>in</strong> ........................................... 9511.10 Private drivers who have an episode of severe hypoglycemia ................................ 9811.11 Private drivers who have an episode of hypoglycemia unawareness................... 10011.12 Private drivers who have persistent hypoglycemia unawareness ........................ 10111.13 Commercial drivers who have an episode of severe hypoglycemia ..................... 10311.14 Commercial drivers who have an episode of hypoglycemia unawareness.......... 10511.15 Commercial drivers who have persistent hypoglycemia unawareness ............... 10711.16 Doc<strong>to</strong>r’s report on commercial driver with diabetes on <strong>in</strong>sul<strong>in</strong> ........................... 10811.17 <strong>Drive</strong>r’s report – commercial driver with diabetes on <strong>in</strong>sul<strong>in</strong> ............................. 110Chapter 12: Peripheral Vascular Diseases ............................................................................. 112BACKGROUND ......................................................................................................................... 11212.1 About peripheral vascular diseases ........................................................................... 11212.2 Prevalence and <strong>in</strong>cidence of peripheral vascular diseases .................................... 11312.3 Peripheral vascular diseases and adverse driv<strong>in</strong>g outcomes ................................ 11412.4 Effect of peripheral vascular diseases on functional ability <strong>to</strong> drive ................... 11412.5 Compensation ............................................................................................................... 116GUIDELINES ............................................................................................................................. 11712.6 Private and commercial drivers with peripheral arterial disease ........................ 11712.7 Private drivers who have an aneurysm or dissection ............................................. 11912.8 Private and commercial drivers who have had surgery for an aneurysm ordissection ....................................................................................................................... 12012.9 Commercial drivers who have an aneurysm or dissection .................................... 12112.10 Private and commercial drivers who have deep-ve<strong>in</strong> thrombosis........................ 122Chapter 13: Musculoskeletal Conditions................................................................................ 123BACKGROUND ......................................................................................................................... 12313.1 About musculoskeletal conditions ............................................................................. 12313.2 Prevalence and <strong>in</strong>cidence of musculoskeletal conditions ....................................... 12313.3 Musculoskeletal conditions and adverse driv<strong>in</strong>g outcomes ................................... 12413.4 Effect of musculoskeletal conditions on functional ability <strong>to</strong> drive ..................... 12413.5 Compensation ............................................................................................................... 125GUIDELINES ............................................................................................................................. 12713.6 Private and commercial drivers who have lost a limb ........................................... 12713.7 Private and commercial drivers who have a chronic musculoskeletal condition......................................................................................................................................... 128Chapter 14: Chronic Renal Disease......................................................................................... 130BACKGROUND ......................................................................................................................... 13014.1 About chronic renal disease ....................................................................................... 13014.2 Prevalence and <strong>in</strong>cidence of chronic renal disease ................................................. 13014.3 Chronic renal disease and adverse driv<strong>in</strong>g outcomes ............................................ 13114.4 Effect of chronic renal disease on functional ability <strong>to</strong> drive ................................ 13114.5 Compensation ............................................................................................................... 132GUIDELINES ............................................................................................................................. 13314.6 Private and commercial drivers with stage 1 or 2 renal disease .......................... 133vi
Change language